Adverse Events following AstraZeneca COVID-19 Vaccine in Saudi Arabia: A Cross-Sectional Study among Healthcare and Nonhealthcare Workers.
- Published in:
- Intervirology, 2022, v. 65, n. 2, p. 104, doi. 10.1159/000519456
- By:
- Publication type:
- Article
Works in Intervirology, 2022, Vol 65, Issue 2
Results: 6
1
2
Real-World Single-Center Comparison of the Safety and Efficacy of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide in Patients with Chronic Hepatitis B.
- Published in:
- Intervirology, 2022, v. 65, n. 2, p. 94, doi. 10.1159/000519440
- By:
- Publication type:
- Article
3
Updating on Roles of HIV Intrinsic Factors: A Review of Their Antiviral Mechanisms and Emerging Functions.
- Published in:
- Intervirology, 2022, v. 65, n. 2, p. 67, doi. 10.1159/000519241
- By:
- Publication type:
- Article
4
HIV-HCV Coinfection: Prevalence and Treatment Outcomes in Malaysia.
- Published in:
- Intervirology, 2022, v. 65, n. 2, p. 87, doi. 10.1159/000518836
- By:
- Publication type:
- Article
5
Low-Intensity Ultrasound as a Novel Strategy to Improve the Cytotoxic Effect of Oncolytic Reovirus on Colorectal Cancer Model Cells.
- Published in:
- Intervirology, 2022, v. 65, n. 2, p. 110, doi. 10.1159/000519492
- By:
- Publication type:
- Article
6
Prevalence of Hepatitis B Virus Infection Markers among Patients of the Ibn Sina University Hospital Center (Rabat, Morocco).
- Published in:
- Intervirology, 2022, v. 65, n. 2, p. 80, doi. 10.1159/000518618
- By:
- Publication type:
- Article